Special and primary election results for State House District 34B primary, St. Paul City Council and more

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

A vaccine candidate for the novel coronavirus 

hit a new milestone and entered phase two of clinical trials

 last week. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use? 

This vaccine is far from the only trial underway, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.

Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with a vaccinologist and a virologist about how the vaccine development process works; the speed of the science happening during a pandemic; and answer listener questions.

Subscribe to the MPR News with Kerri Miller podcast on: 

Health

Shows

Big Books & Bold Ideas with Kerri Miller

COVID-19

Host

Author

As part of our weekly look at the science of the novel coronavirus, we focus on vaccine development this Tuesday with a vaccinologist and a virologist.

Coming up: Researchers discuss vaccine development, continued efforts on novel coronavirus

Go Deeper.

Like this?